POTENSI PROPOLIS SEBAGAI ANTIDIABETES BERDASARKAN ANALISIS SAYATAN HISTOLOGI PANKREAS
Abstract
Full Text:
PDFReferences
Wilson, L. M. & Price, S. A. 1992. Patofisiologi: Konsep Klinis Proses-Proses Penyakit. Edisi Keempat. Alih bahasa: Peter Anugrah. Penerbit buku Kedokteran EGC. Jakarta, 78-92.
Can, A., Nuriye., Ozov, N., Bolkent, S., & Yanardag, R. 2004. Effect of Aloe vera leaf and pulp extracts on the liver in type II diabetic rat models. Bio. Pharm. Bull. 27 (5), 694-698.
Evans, J. L., Goldfine, I. D., Maddux, B. A. & Grodsky, G.M. 2003. Oxidative stress-activated signaling pathway mediators of insulin resistance and β cells disfuctions?. Diabetes, 52 (1), 1-8.
Robertson, R. P., Harmon, J., Tran, P. O., Tanaka, Y., & Takahashi, H. 2003. Glucose toxycity in beta-cells, type 2 diabetes, good radical gone bad, and the gluthation connection. Diabetes, 52, 581-587.
Jee, S. H., Kim, H. J., & Lee, J. 2005. Obesity insulin resistance and cancer risk. Yonsei Med Journal, 46, 449-455.
Okutan, H., Ozcelik N, Yilmaz H. R., & Uz, E. 2005. Effect of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin. Biochem., 38 (2), 192-196.
Niskanen, L. K., Salonen, J. T., Nyyssonen, K., & Uusitupa, M. I. 1995. Plasma lipid peroxidation and hyperglycaemia: a connection through hyperinsulinaemia? Diabetic Medicine, 12, 802-808.
Santini, S. A., Marra, G., Giardina, B., Cotroneo, P., Mordente, A., Martorana, G. E., Manto, A., & Ghirlanda, G. 1997. Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes, 46, 1853-1858.
Cederberg, J., Basu, S., & Eriksson, U. J. 2001. Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy. Diabetologia, 44, 766-774.
Kaneto, H., Kajimoto, Y., Miyagawa, J., & Hori, M. 1999. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic β-cells againts glucose toxicity. Diabetes, 48, 2398-2406.
Houstin. N., Rosen. E. D., & Lander. E.S. 2006. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature, 440, 944-948.
Bonnard. C., Durand. A., Peyrol. S. Chanseaume. E., Chauvin M. A., Mario. B., Vidal. H., & Rieusset. J. 2008. Mitochondrial dysfunvtion results from oxidative stress in the skeletal muscle of diet-induced insulin-resistence mice. J. Clin. Invest, 118, 789-800.
Kumashiro. N., Tamura. Y., Uchida. T., Ogihara. T., Fujitani. Y., Hirose. T., Mochizuki. H., Kawamori. H., & Watada. H. 2008. Impact of oxidative stress and peroxixome proliferator-activated receptor γ coactivator-1α in hepatic insulin resistance. Diabetes, 57, 1083-2091.
Mercuri, F., Quagliaro, L., & Ceriello, A. 2000. Oxidative stress evaluation in diabetes. Diabetes Technol. Ther., 2, 589-600.
West, I. C. 2000. Radical and oxidative stress in diabetes. Diabetic Med., 17, 171-180.
Cam, M., Yavuz, O., Guven, A., Ercan, F., & Sutundag, N. 2003. Protective effects of chronic melatonin treatment againts renal inury in streptozotocin-induced diabetic rats. J. Pineal Phys., 35, 212-220.
Halliwel, B., & Gutteridge. 1999. Free radical in biology and medicine. 3rd ed. Oxford Univ Press, New York.
Auslander, W., Haire-Joshu, D., Houston, C., Rhee, C.W., & Williams, J. H. 2002. A controlled evaluation of staging dietary patterns to reduce the risk of diabetes. Diabetes Care, 25, 809-814.
Marjani, A. 2005. Plasma lipid peroxidation zinc and erthrocyte Cu-Zn superoxide dismutase enzyme activity in patient with type 2 diabetes mellitus. Internet Endocrinol, 2 (1), 1647-1648.
Nobercourt, E., Jacqueminet, S., Hanset, B., Chantepie, S., Grimaldi, A., Chapman M. J., & Kontush, A. 2005. Defective antioxidative activity of small dense HDL particle in type 2 diabetes: relationship to elevated oxidative stress and hyperglicemia. Diabetologia, 48 (3), 529-538.
Rohilla, A., & Ali, S. 2012. Alloxan induced diabetes: mechanisms dan effects, Int Journal of Research in Pharmaceutical and Biomedical Science, 3, 819-822.
Shaw, J. E., Saltiel, A. R., & Zimmet, P. Z. (2010) : Global estimates of the prevalence of 2010 anda 2030. Diabetes Research and Clinical Practice, 87: 4-14.
Shulman, G. I. 2000. Cellular mechanism of insulin resistance. The Journal of Clinical Investigation, 106 (2), 19-26.
Alarcon, F. J., Roman R., Flores, J. L., & Aguirre, F. 2002. Investigation on the hypoglicemic effect of extracts of four Mexican medicinal plant in normal and alloxan-induced diabetic mice. Phytotherapy Research, 16, 383-386.
Szkudelski, T. 2001. The Mechanism of alloxan and streptozotocin action β cells of the rat pancreas. Physiology, 50, 536-546.
Akhlaghi, M., & Bandy, B. 2009. Mechanism of flavonoid protection againts myocardial oschemia-reperfusion injury. J. Biol. Mol. Cardio., 46, 309-317.
DOI: http://dx.doi.org/10.22373/ekw.v1i2.344
Refbacks
- There are currently no refbacks.
Copyright (c) 2015 Author
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
P-ISSN : 2460-8912
E-ISSN : 2460-8920
ELKAWNIE
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Elkawnie: Journal of Islamic Science and Technology in 2022. Published by Faculty of Science and Technology in cooperation with Center for Research and Community Service (LP2M), UIN Ar-Raniry Banda Aceh, Aceh, Indonesia.
View full page view stats report click here